Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these receptors, https://hassanarrb146639.estate-blog.com/35326785/setmelanotide-a-promising-new-treatment-for-obesity